Comparison and Analysis of the Drug-Resistance Mechanism of Osimertinib- and Almonertinib-Resistant Cell Lines
Conclusions: These findings indicated that almonertinib and osimertinib exhibited distinct resistance mechanisms in vitro, underscoring the need for tailored treatment approaches.
Saved in:
| Main Authors: | Chuangjie Zheng, Yingfang Ren, Ke Wang, Xinrong Chen, Jiahao Tao, Cuifen Zhang, Zeyu Liu, Lingling Sun, Linzhu Zhai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Analytical Cellular Pathology |
| Online Access: | http://dx.doi.org/10.1155/ancp/5578693 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bleomycin-induced flagellate-like skin pigmentation in a 15-year-old girl: a case report and review
by: Xinrong Chen, et al.
Published: (2025-08-01) -
Safety and efficacy of rechallenge with immune checkpoint inhibitors and anlotinib in advanced non-small cell lung cancer without targetable driver mutations: a retrospective analysis
by: Xinrong Chen, et al.
Published: (2025-05-01) -
Anlotinib Plus Osimertinib in Osimertinib‐Resistant Nonsquamous Nonsmall Cell Lung Cancer With Gradual Progression: A Retrospective Study
by: Yu Hua, et al.
Published: (2025-05-01) -
The potential role of next-generation sequencing in identifying MET amplification and disclosing resistance mechanisms in NSCLC patients with osimertinib resistance
by: Xiao Xiao, et al.
Published: (2024-10-01) -
Neratinib as a Potential Therapeutic for Mutant RAS and Osimertinib-Resistant Tumours
by: Paul Dent, et al.
Published: (2022-09-01)